The wearable cardiac devices market is anticipated to exhibit substantial growth by 2027 owing to soaring preference for convenient and minimally invasive medical devices among patients across the globe.

Wearable technology has opened up new avenues for the diagnosis and management of cardiovascular illnesses and associated risk factors. Technologies that are commonly used in clinical settings, such as heart rate and rhythm monitors and blood pressure monitors, are now available directly to patients via wearable cardiac devices. Notably, rapid technological advancements in wearable cardiac devices have fueled industry growth in recent years.

Moreover, recent studies have indicated that the ongoing COVID-19 pandemic has been shown to cause cardiovascular diseases in patients above the age of 60 years and those suffering from existing underlying health conditions. As a result, rising incidences of heart-related diseases globally have driven product demand during the pandemic.

Furthermore, to accommodate the surging demand for non-invasive cardiac monitoring devices, industry players are employing lucrative strategies, which has positively impacted the overall business dynamics. For instance, in September 2021, ZOLL Medical Corporation, a key medical devices manufacturer, announced the acquisition of Itamar Medical Ltd., a prominent digital health and medical device company.

The deal enabled ZOLL to expand its commercial footprint to include home sleep medicine for patients with untreated and undiagnosed sleep apnea by leveraging Itamar’s digital health solutions and its WatchPAT technology.

The wearable cardiac devices market has been segregated on the basis of application, product, and region. With respect to product, the market has further been categorized into defibrillators, Holter monitors, patch, and others.

The others sub-segment is projected to observe considerable growth over the study timeline owing to increasing focus on innovations in the field of cardiac health monitoring. Moreover, constant product development and launch of advanced devices, such as wearable ECG and MCT, by industry players are likely to augment segmental growth over the review period.

In terms of application, the wearable cardiac devices market has been divided into remote patient monitoring, home healthcare, and others. The home healthcare sub-segment is slated to progress at a notable rate over 2021-2027 on account of rising awareness among patients pertaining to the ease and convenience of advanced technologies. Additionally, growing preference for home healthcare is estimated to boost segmental development in the coming years.

From the regional point of view, the Latin America wearable cardiac devices market is set to garner a sizable share in the global industry revenue by the end of the forecast period due to improving access to developing technologies, coupled with mounting emphasis of industry players on business expansion in emerging countries across LATAM. Furthermore, rising expenditure on healthcare is expected to foster regional market outlook in the forthcoming years.